Patents by Inventor GIULIA BORTOLUSSI

GIULIA BORTOLUSSI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF HYPERBILIRUBINEMIA
    Publication number: 20230414724
    Abstract: The invention relates to a nucleic acid sequence useful in the treatment of hyperbilirubinemia, in particular in the treatment of Crigler-Najjar syndrome. More particularly, the nucleic acid sequence of the present invention is a codon-optimized UGT1A1 coding sequence.
    Type: Application
    Filed: June 22, 2023
    Publication date: December 28, 2023
    Inventors: FEDERICO MINGOZZI, GIUSEPPE RONZITTI, FANNY COLLAUD, ANDRÉS MURO, GIULIA BORTOLUSSI
  • TREATMENT OF HYPERBILIRUBINEMIA
    Publication number: 20190374619
    Abstract: The invention relates to a nucleic acid sequence useful in the treatment of hyperbilirubinemia, in particular in the treatment of Crigler-Najjar syndrome. More particularly, the nucleic acid sequence of the present invention is a codon-optimized UGT1A1 coding sequence.
    Type: Application
    Filed: August 28, 2019
    Publication date: December 12, 2019
    Inventors: FEDERICO MINGOZZI, GIUSEPPE RONZITTI, FANNY COLLAUD, ANDRÉS MURO, GIULIA BORTOLUSSI
  • Treatment of hyperbilirubinemia
    Patent number: 10471132
    Abstract: The invention relates to a nucleic acid sequence useful in the treatment of hyperbilirubinemia, in particular in the treatment of Crigler-Najjar syndrome. More particularly, the nucleic acid sequence of the present invention is a codon-optimized UGT1A1 coding sequence.
    Type: Grant
    Filed: April 27, 2015
    Date of Patent: November 12, 2019
    Assignees: GENETHON, INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY
    Inventors: Federico Mingozzi, Giuseppe Ronzitti, Fanny Collaud, Andrés Muro, Giulia Bortolussi
  • TREATMENT OF HYPERBILIRUBINEMIA
    Publication number: 20170028036
    Abstract: The invention relates to a nucleic acid sequence useful in the treatment of hyperbilirubinemia, in particular in the treatment of Crigler-Najjar syndrome. More particularly, the nucleic acid sequence of the present invention is a codon-optimized UGT1A1 coding sequence.
    Type: Application
    Filed: April 27, 2015
    Publication date: February 2, 2017
    Inventors: FEDERICO MINGOZZI, GIUSEPPE RONZITTI, FANNY COLLAUD, ANDRÉS MURO, GIULIA BORTOLUSSI